Plunkett Research Online: Tyme Technologies Inc

TYME TECHNOLOGIES INC (TYME) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that.....


TYME TECHNOLOGIES INC

Ticker: TYME
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 212 400-6900
Fax:
Address: 1330 Avenue of the Americas
New York, NY 10005 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Richard CunninghamCEO/Director
Frank PorfidoCFO
See More
Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture